• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于增强黏膜免疫的可吸入疫苗纳米技术。

Nanotechnology of inhalable vaccines for enhancing mucosal immunity.

作者信息

Qin Li, Sun Yanhua, Gao Nan, Ling Guixia, Zhang Peng

机构信息

Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang, 110016, China.

Shandong Provincial Key Laboratory of Microparticles Drug Delivery Technology, Qilu Pharmaceutical Co. Ltd., No. 243, Gongyebei Road, Jinan, 250100, China.

出版信息

Drug Deliv Transl Res. 2024 Mar;14(3):597-620. doi: 10.1007/s13346-023-01431-7. Epub 2023 Sep 25.

DOI:10.1007/s13346-023-01431-7
PMID:37747597
Abstract

Vaccines are the cornerstone of world health. The majority of vaccines are formulated as injectable products, facing the drawbacks of cold chain transportation, needle-stick injuries, and primary systemic immunity. Inhalable vaccines exhibited unique advantages due to their small dose, easy to use, quick effect, and simultaneous induction of mucosal and systemic responses. Facing global pandemics, especially the coronavirus disease 2019 (COVID-19), a majority of inhalable vaccines are in preclinical or clinical trials. A better understanding of advanced delivery technologies of inhalable vaccines may provide new scientific insights for developing inhalable vaccines. In this review article, detailed immune mechanisms involving mucosal, cellular, and humoral immunity were described. The preparation methods of inhalable vaccines were then introduced. Advanced nanotechnologies of inhalable vaccines containing inhalable nucleic acid vaccines, inhalable adenovirus vector vaccines, novel adjuvant-assisted inhalable vaccines, and biomaterials for inhalable vaccine delivery were emphatically discussed. Meanwhile, the latest clinical progress in inhalable vaccines for COVID-19 and tuberculosis was discussed.

摘要

疫苗是全球健康的基石。大多数疫苗被制成注射剂,面临冷链运输、针刺伤和主要诱导全身免疫等缺点。吸入式疫苗因其剂量小、使用方便、起效快以及能同时诱导黏膜和全身反应而展现出独特优势。面对全球大流行,尤其是2019冠状病毒病(COVID-19),大多数吸入式疫苗正处于临床前或临床试验阶段。更好地了解吸入式疫苗的先进递送技术可能为开发吸入式疫苗提供新的科学见解。在这篇综述文章中,描述了涉及黏膜免疫、细胞免疫和体液免疫的详细免疫机制。接着介绍了吸入式疫苗的制备方法。重点讨论了吸入式疫苗的先进纳米技术,包括吸入式核酸疫苗、吸入式腺病毒载体疫苗、新型佐剂辅助吸入式疫苗以及用于吸入式疫苗递送的生物材料。同时,还讨论了COVID-19和结核病吸入式疫苗的最新临床进展。

相似文献

1
Nanotechnology of inhalable vaccines for enhancing mucosal immunity.用于增强黏膜免疫的可吸入疫苗纳米技术。
Drug Deliv Transl Res. 2024 Mar;14(3):597-620. doi: 10.1007/s13346-023-01431-7. Epub 2023 Sep 25.
2
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19.吸入型疫苗递呈在抗击呼吸道病毒中的应用:2021 年最新进展综述及其对 COVID-19 的影响。
Expert Rev Vaccines. 2022 Jul;21(7):957-974. doi: 10.1080/14760584.2021.1903878. Epub 2021 Aug 25.
3
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.鼻腔内递送表达一种改良的刺突蛋白和一种遗传佐剂的腺病毒载体疫苗可提供针对 SARS-CoV-2 的持久黏膜免疫。
Antiviral Res. 2023 Aug;216:105656. doi: 10.1016/j.antiviral.2023.105656. Epub 2023 Jun 14.
4
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.用于 SARS-CoV-2 的黏膜疫苗:希望战胜经验。
EBioMedicine. 2023 Jun;92:104585. doi: 10.1016/j.ebiom.2023.104585. Epub 2023 May 3.
5
Intranasal COVID-19 vaccines: From bench to bed.鼻内 COVID-19 疫苗:从实验室到临床。
EBioMedicine. 2022 Feb;76:103841. doi: 10.1016/j.ebiom.2022.103841. Epub 2022 Jan 24.
6
Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines.黏膜免疫系统的分子基础:从基本概念到基于脂质体疫苗的进展。
Nanomedicine (Lond). 2010 Dec;5(10):1617-40. doi: 10.2217/nnm.10.128.
7
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development.病毒载体结核病疫苗的研究进展及结核病疫苗研发的最新发现。
Front Immunol. 2022 Jun 23;13:895020. doi: 10.3389/fimmu.2022.895020. eCollection 2022.
8
Mucosal vaccines - fortifying the frontiers.黏膜疫苗——强化前沿。
Nat Rev Immunol. 2022 Apr;22(4):236-250. doi: 10.1038/s41577-021-00583-2. Epub 2021 Jul 26.
9
Inhalable SARS-CoV-2 Mimetic Particles Induce Pleiotropic Antigen Presentation.吸入型 SARS-CoV-2 模拟颗粒诱导多效性抗原呈递。
Biomacromolecules. 2022 Mar 14;23(3):1158-1168. doi: 10.1021/acs.biomac.1c01447. Epub 2022 Jan 26.
10
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.鼻腔内纳米乳佐剂 S-2P 疫苗在仓鼠中显示出保护作用,并在小鼠中诱导全身性、细胞介导和黏膜免疫。
PLoS One. 2022 Nov 2;17(11):e0272594. doi: 10.1371/journal.pone.0272594. eCollection 2022.

引用本文的文献

1
mRNA Technology and Mucosal Immunization.信使核糖核酸技术与黏膜免疫
Vaccines (Basel). 2024 Jun 17;12(6):670. doi: 10.3390/vaccines12060670.

本文引用的文献

1
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters.一种鼻腔内疫苗,包含 SARS-CoV-2 刺突受体结合域蛋白,被包裹在甘露糖修饰壳聚糖纳米颗粒中,可在仓鼠中提供保护。
Sci Rep. 2023 Jul 26;13(1):12115. doi: 10.1038/s41598-023-39402-0.
2
Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model.构建可吸入型重组 M2e-FP 表达枯草芽孢杆菌孢子疫苗并评估其在小鼠模型中预防流感的保护效果。
Vaccine. 2023 Jul 5;41(30):4402-4413. doi: 10.1016/j.vaccine.2023.05.074. Epub 2023 Jun 10.
3
Long-acting vaccine delivery systems.
长效疫苗输送系统。
Adv Drug Deliv Rev. 2023 Jul;198:114897. doi: 10.1016/j.addr.2023.114897. Epub 2023 May 22.
4
Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.优化脂质纳米粒的配方和雾化用于吸入 mRNA。
Int J Pharm. 2023 Jun 10;640:123050. doi: 10.1016/j.ijpharm.2023.123050. Epub 2023 May 16.
5
Pulmonary Application of Novel Antigen-Loaded Chitosan Nano-Particles Co-Administered with the Mucosal Adjuvant C-Di-AMP Resulted in Enhanced Immune Stimulation and Dose Sparing Capacity.将新型负载抗原的壳聚糖纳米颗粒与黏膜佐剂C-Di-AMP联合应用于肺部,可增强免疫刺激并具有剂量节省能力。
Pharmaceutics. 2023 Apr 13;15(4):1238. doi: 10.3390/pharmaceutics15041238.
6
Aerosol pulmonary immune engineering.气溶胶肺部免疫工程。
Adv Drug Deliv Rev. 2023 Aug;199:114831. doi: 10.1016/j.addr.2023.114831. Epub 2023 Apr 24.
7
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines.针对 SARS-CoV-2 疫苗的上呼吸道黏膜免疫。
Trends Mol Med. 2023 Apr;29(4):255-267. doi: 10.1016/j.molmed.2023.01.003. Epub 2023 Jan 23.
8
Aluminum-based metal-organic framework nanoparticles as pulmonary vaccine adjuvants.铝基金属有机骨架纳米粒子作为肺部疫苗佐剂。
J Nanobiotechnology. 2023 Feb 3;21(1):39. doi: 10.1186/s12951-023-01782-w.
9
Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS-CoV-2.无针注射系统递送 ZyCoV-D DNA 疫苗可提高恒河猴针对 SARS-CoV-2 的免疫原性和保护效力。
J Med Virol. 2023 Feb;95(2):e28484. doi: 10.1002/jmv.28484.
10
Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung.用于肺部吸入信使 RNA 递送至肺部的通用聚合物制剂。
Nat Mater. 2023 Mar;22(3):369-379. doi: 10.1038/s41563-022-01404-0. Epub 2022 Nov 28.